 | | PRD_000904 | | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C27 H52 N4 O5 | | Description: | vinylketone carmaphycin analogue VNK1, double bound form | | Definition date: | 2014-01-29 | | Last modified: | 2017-05-04 |
|
 | | PRD_001077 | | Name: | Cul1WHB-Dcn1P-stapled acetylated | | Formula: | C71 H133 N17 O16 Se | | Definition date: | 2012-12-12 | | Last modified: | 2017-05-04 |
|
 | | PRD_001131 | | Name: | GRAMICIDIN A | | Formula: | C90 H133 N19 O17 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2013-07-02 | | Last modified: | 2017-05-04 |
|
 | | PRD_001132 | | Name: | CYCLOSPORIN D | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | | Definition date: | 2013-07-02 | | Last modified: | 2017-05-04 |
|
 | | PRD_001238 | | Name: | PEPSTATIN ANALOGUE ISOVALERYL-VAL-VAL-STA-O-ET | | Formula: | C25 H47 N3 O6 | | Definition date: | 2014-06-04 | | Last modified: | 2017-05-04 |
|
 | | PRD_002251 | | Name: | 3-[(3-hydroxyphenyl)methyl]-10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | | Formula: | C34 H50 N4 O8 | | Definition date: | 2017-01-25 | | Last modified: | 2017-05-04 |
|
 | | PRD_002240 | | Name: | 18-methoxy-2,11,17-trimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C30 H44 N4 O6 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002241 | | Name: | 3-[(3-hydroxyphenyl)methyl]-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | | Formula: | C30 H42 N4 O6 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002245 | | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-17-methyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C35 H46 N4 O7 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002246 | | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-2,17-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C36 H48 N4 O7 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002248 | | Name: | (4S,7S,17R)-7-(hydroxymethyl)-4-(2-methylpropyl)-17-pentyl-1-oxa-3,6,11-triazacycloheptadecane-2,5,10-trione | | Formula: | C23 H43 N3 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2017-01-11 |
|
 | | PRD_002249 | | Name: | (4S,7S,17S)-17-(3-chlorophenyl)-7-(hydroxymethyl)-4-(2-methylpropyl)-1-oxa-3,6,11-triazacycloheptadecane-2,5,10-trione | | Formula: | C24 H36 Cl N3 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2017-01-11 |
|
 | | PRD_002186 | | Name: | 6-ammonio-N-[3-(9H-fluoren-9-yl)propanoyl]-L-norleucyl-6-ammonio-L-norleucyl-L-alpha-glutamyl-L-threonyl-L-alpha-glutamyl-L-valine | | Formula: | C47 H70 N8 O13 | | Definition date: | 2016-08-17 | | Last modified: | 2016-08-17 |
|
 | | PRD_002175 | | Name: | N,beta,beta-trimethyl-L-phenylalanyl-N-[(3S,4Z)-5-carboxy-2-methylhex-4-en-3-yl]-N,3-dimethyl-L-valinamide | | Formula: | C27 H43 N3 O4 | | Definition date: | 2016-07-27 | | Last modified: | 2016-07-27 |
|
 | | PRD_002237 | | Name: | (2R,4R)-4-{[(2-{(1R,3R)-1-(acetyloxy)-4-methyl-3-[methyl(N-{[(2S)-1-methylpiperidin-2-yl]carbonyl}-D-isoleucyl)amino]pentyl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoic acid | | Formula: | C38 H57 N5 O7 S | | Definition date: | 2016-07-27 | | Last modified: | 2016-07-27 |
|
 | | PRD_002231 | | Name: | N~2~-{(4R,7S,10R,13R,16R,19S,24R)-19,24-diamino-16-(3-{[amino(iminio)methyl]amino}propyl)-7-(4-azaniumylbutyl)-10-[(1R)-1-hydroxyethyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18,23-hexaoxo-1,2-dithia-5,8,11,14,17,22-hexaazacyclopentacosane-4-carbonyl}-L-leucinamide | | Formula: | C43 H73 N15 O9 S2 | | Definition date: | 2016-06-01 | | Last modified: | 2016-06-01 |
|
 | | PRD_001260 | | Name: | PAMK PEPTIDE Inhibitor | | Formula: | C48 H80 N12 O15 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002162 | | Name: | N-[(4-carbamimidamidobutyl)carbamoyl]-L-seryl-N-[(2S)-5-{[amino(iminio)methyl]amino}-1-oxopentan-2-yl]-L-valinamide | | Formula: | C20 H41 N10 O5 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002201 | | Name: | (phenylmethyl) ~{N}-[(8~{S},11~{S},14~{S})-8-(hydroxymethyl)-11-(2-methylpropyl)-5,10,13-tris(oxidanylidene)-1,4,9,12,17,18-hexazabicyclo[14.2.1]nonadeca-16(19),17-dien-14-yl]carbamate | | Formula: | C26 H37 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002202 | | Name: | (phenylmethyl) ~{N}-[(9~{S},12~{S},15~{S})-9-(hydroxymethyl)-12-(2-methylpropyl)-6,11,14-tris(oxidanylidene)-1,5,10,13,18,19-hexazabicyclo[15.2.1]icosa-17(20),18-dien-15-yl]carbamate | | Formula: | C27 H39 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002203 | | Name: | (phenylmethyl) ~{N}-[(12~{S},15~{S},18~{S})-15-(cyclohexylmethyl)-12-(hydroxymethyl)-9,14,17-tris(oxidanylidene)-1,8,13,16,21,22-hexazabicyclo[18.2.1]tricosa-20(23),21-dien-18-yl]carbamate | | Formula: | C33 H49 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002222 | | Name: | N-(3-bromo-4-methoxybenzene-1-carbonyl)-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | | Formula: | C38 H53 Br N7 O11 P | | Definition date: | 2016-02-24 | | Last modified: | 2016-02-24 |
|
 | | PRD_002200 | | Name: | N-benzoyl-L-leucyl-L-leucine | | Formula: | C19 H28 N2 O4 | | Definition date: | 2016-02-17 | | Last modified: | 2016-02-17 |
|
 | | PRD_002217 | | Name: | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine | | Formula: | C24 H27 N5 O7 | | Definition date: | 2016-02-03 | | Last modified: | 2016-02-04 |
|
 | | PRD_001259 | | Name: | acyclic trypsin inhibitor | | Formula: | C67 H108 N18 O19 S2 | | Definition date: | 2016-01-13 | | Last modified: | 2016-01-13 |
|
